Literature DB >> 9724523

Selective recognition and cleavage of RNA loop structures by Ni(II).Xaa-Gly-His metallopeptides.

I J Brittain1, X Huang, E C Long.   

Abstract

The recognition and cleavage of tRNAPhe and the TAR RNA of HIV-1 by metallopeptides of the general form Ni(II).Xaa-Gly-His (where Xaa is Gly, Lys, or Arg) were investigated. The results of RNA cleavage analyses suggest that KHSO5- or magnesium monoperoxyphthalate-activated metallopeptides (1) induce nucleobase damage which requires aniline acetate for complete RNA strand scission and (2) selectively target the loops of stem-loop structures of the above-named substrates. In targeting RNA loop regions, the metallopeptides may be sensitive to intraloop structural features, including the overall structural environment of the loop itself and possibly the presence of intraloop hydrogen bonding. Overall, these results suggest that the metallopeptides interact selectively within a loop, in a fashion reminiscent of many RNA binding proteins, instead of targeting RNA single-stranded character alone. These observations further suggest a possible metallopeptide-based strategy for the molecular recognition of native RNA structures and insight with regard to the general features available for ligand binding site discrimination.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724523     DOI: 10.1021/bi9806605

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Highly efficient endonucleolytic cleavage of RNA by a Cys(2)His(2) zinc-finger peptide.

Authors:  W F Lima; S T Crooke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 2.  De novo design of helical bundles as models for understanding protein folding and function.

Authors:  R B Hill; D P Raleigh; A Lombardi; W F DeGrado
Journal:  Acc Chem Res       Date:  2000-11       Impact factor: 22.384

3.  Proton and metal ion-dependent assembly of a model diiron protein.

Authors:  A Pasternak; J Kaplan; J D Lear; W F Degrado
Journal:  Protein Sci       Date:  2001-05       Impact factor: 6.725

4.  Recognition mechanism of p63 by the E3 ligase Itch: novel strategy in the study and inhibition of this interaction.

Authors:  Alessia Bellomaria; Gaetano Barbato; Gerry Melino; Maurizio Paci; Sonia Melino
Journal:  Cell Cycle       Date:  2012-08-30       Impact factor: 4.534

5.  Retrostructural analysis of metalloproteins: application to the design of a minimal model for diiron proteins.

Authors:  A Lombardi; C M Summa; S Geremia; L Randaccio; V Pavone; W F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

6.  Recognition and quantification of binary and ternary mixtures of isomeric peptides by the kinetic method: metal ion and ligand effects on the dissociation of metal-bound complexes.

Authors:  Lianming Wu; Karel Lemr; Tenna Aggerholm; R Graham Cooks
Journal:  J Am Soc Mass Spectrom       Date:  2003-02       Impact factor: 3.109

7.  The leucine zipper domains of the transcription factors GCN4 and c-Jun have ribonuclease activity.

Authors:  Yaroslav Nikolaev; Christine Deillon; Stefan R K Hoffmann; Laurent Bigler; Sebastian Friess; Renato Zenobi; Konstantin Pervushin; Peter Hunziker; Bernd Gutte
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

8.  Metallotherapeutics: novel strategies in drug design.

Authors:  Lalintip Hocharoen; James A Cowan
Journal:  Chemistry       Date:  2009-09-07       Impact factor: 5.236

9.  Cellular activity of Rev response element RNA targeting metallopeptides.

Authors:  Yan Jin; J A Cowan
Journal:  J Biol Inorg Chem       Date:  2007-03-14       Impact factor: 3.862

Review 10.  N-Terminal Cu-Binding Motifs (Xxx-Zzz-His, Xxx-His) and Their Derivatives: Chemistry, Biology and Medicinal Applications.

Authors:  Paulina Gonzalez; Karolina Bossak; Ewelina Stefaniak; Christelle Hureau; Laurent Raibaut; Wojciech Bal; Peter Faller
Journal:  Chemistry       Date:  2018-03-24       Impact factor: 5.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.